Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2021-09-20

FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA notice of a supplemental labeling application for VENLAFAXINE by Alembic Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

SUPPL AP for VENLAFAXINE (VENLAFAXINE)